---
$id: https://graph.org.ai/products/commodity/51111726
$type: Product
source: UNSPSC
code: "51111726"
title: "Ambazone"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ambazone

**UNSPSC Code**: 51111726
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antineoplastic antibiotic with the molecular formula C8H11N7S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BYK4592A3Q, chemically known as 1,4-benzoquinone guanylhydrazone thiosemicarbazone but generally known as ambazone, which bears US NIH Compound Identifier 1549158. European Medicines Agency schedules Ambazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12841MIG. The term AMBAZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules ambazone in its Anatomical Therapeutic Chemical (ATC) Classification. AMBAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ambazone under HS 29309085 and SITC 51549. As of Q4 2014, AMBAZONE remains the US FDA Preferred Term for this commodity. Ambazone bears US NLM identifiers UMLS ID C0043983 and NCI Concept Code C72627. SMILES: S=C(/N=N/C1CCC(N/N=C(/N)N)CC1)N.

